Literature DB >> 14675043

Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.

Margaret K Elliott1, Tambi Jarmi, Phil Ruiz, Yuanyuan Xu, V Michael Holers, Gary S Gilkeson.   

Abstract

BACKGROUND: The alternative complement pathway (AP) is activated in individuals with lupus nephritis and in murine models of systemic lupus erythematosus, including MRL/lpr mice. A previous study from our laboratory evaluated the development of renal disease in MRL/lpr mice genetically deficient in factor B (Bf-/-), a protein necessary for AP activation. MRL/lpr Bf-/- mice developed less renal disease and had improved survival; however, these mice were also a different major histocompatibility complex (MHC) haplotype (H-2b) than their wild-type littermates (H-2k) due to the gene for Bf being located in the MHC gene complex. We undertook the current study to determine if the decreased renal disease in MRL/lpr Bf-/- mice was due to the lack of AP activation or the H-2b haplotype by studying the effects of factor D (Df) deficiency, a critical protein for AP activation, on disease development in MRL/lpr mice.
METHODS: Df-deficient mice were backcrossed with MRL/lpr mice for four to nine generations. MRL/lpr H-2k Df-/-, Df+/-, and Df+/+ littermates were evaluated for disease development. Lack of AP activation in MRL/lpr Df-/- mice was determined by the zymosan assay. Serum creatinine levels were measured using a creatinine kit. Proteinuria and autoantibody levels were determined by enzyme-linked immunosorbent assay (ELISA). Sections from one kidney were stained with fluorescein isothiocyanate (FITC) alpha-murine C3 or alpha-murine IgG to detect C3 and IgG deposition. The remaining kidney was cut in half with one half fixed, sectioned, and stained with hematoxylin and eosin and periodic acid-Schiff (PAS) to evaluate pathology and another half fixed in glutaraldehyde and examined via electron microscopy.
RESULTS: MRL/lpr Df-/- mice had similar glomerular IgG deposition, proteinuria and autoantibody levels, as Df+/+ and Df+/- littermates. However, glomerular C3 deposition, serum creatinine levels, and pathologic renal disease were significantly reduced in Df-/- mice. Despite the lack of renal disease in Df-/- mice, life span was not impacted by factor D deficiency.
CONCLUSION: The absence of Df and AP activation is protective against the development of proliferative renal disease in MRL/lpr mice suggesting the similar effect of Bf deficiency in MRL/lpr mice was also due to the lack of AP activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14675043     DOI: 10.1111/j.1523-1755.2004.00371.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  32 in total

1.  The quantitative role of alternative pathway amplification in classical pathway induced terminal complement activation.

Authors:  M Harboe; G Ulvund; L Vien; M Fung; T E Mollnes
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

2.  Markers of childhood lupus nephritis indicating disease activity.

Authors:  Monika Edelbauer; Sudhir Kshirsagar; Magdalena Riedl; Dieter Haffner; Heiko Billing; Burkhard Tönshoff; Sophia Ross; Jörg Dötsch; Oliver Amon; Henry Fehrenbach; Christian Steuber; Antje Beissert; Josef Hager; Gottfried Wechselberger; Lutz T Weber; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

3.  KRN/I-Ag7 mouse arthritis is independent of complement C3.

Authors:  Patricia Y Tsao; Vaishali Arora; Mei Qing Ji; Alexander C Wright; Robert A Eisenberg
Journal:  J Clin Immunol       Date:  2011-07-06       Impact factor: 8.317

Review 4.  Lupus nephritis: the evolving role of novel therapeutics.

Authors:  Brad H Rovin; Samir V Parikh
Journal:  Am J Kidney Dis       Date:  2014-01-07       Impact factor: 8.860

5.  Fragment Bb: evidence for activation of the alternative pathway of the complement system in pregnant women with acute pyelonephritis.

Authors:  Eleazar Soto; Roberto Romero; Edi Vaisbuch; Offer Erez; Shali Mazaki-Tovi; Juan Pedro Kusanovic; Zhong Dong; Tinnakorn Chaiworapongsa; Lami Yeo; Pooja Mittal; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-10

6.  Complement Factor D protects mice from ethanol-induced inflammation and liver injury.

Authors:  Rebecca L McCullough; Megan R McMullen; Megan M Sheehan; Kyle L Poulsen; Sanjoy Roychowdhury; Dian J Chiang; Michele T Pritchard; Juan Caballeria; Laura E Nagy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-03-29       Impact factor: 4.052

7.  Modeling how CD46 deficiency predisposes to atypical hemolytic uremic syndrome.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Barbara Schraml; Timothy H J Goodship; John P Atkinson
Journal:  Mol Immunol       Date:  2006-10-05       Impact factor: 4.407

Review 8.  Complement in Lupus Nephritis: New Perspectives.

Authors:  Lihua Bao; Patrick N Cunningham; Richard J Quigg
Journal:  Kidney Dis (Basel)       Date:  2015-06-30

Review 9.  Properdin: New roles in pattern recognition and target clearance.

Authors:  Claudia Kemper; Dennis E Hourcade
Journal:  Mol Immunol       Date:  2008-08-08       Impact factor: 4.407

10.  Novel targets for immunotherapy in glomerulonephritis.

Authors:  Mary H Foster
Journal:  Biologics       Date:  2008-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.